$260 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 30.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | Neurocrine Biosciences Inc | $16,061,000 | +25.8% | 163,500 | +6.2% | 6.17% | +23.8% |
| CELG | Sell | Celgene Corp | $15,050,000 | -17.9% | 189,522 | -7.8% | 5.78% | -19.2% |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $14,144,000 | +27.2% | 83,222 | +22.0% | 5.43% | +25.2% |
| ILMN | New | Illumina Inc | $12,568,000 | – | 45,000 | +100.0% | 4.83% | – |
| ARRY | Sell | Array Biopharma Inc | $11,647,000 | -16.1% | 694,500 | -18.4% | 4.47% | -17.5% |
| REGN | Sell | Regeneron Pharmaceuticals | $10,808,000 | -12.9% | 31,330 | -13.0% | 4.15% | -14.3% |
| BIIB | Sell | Biogen Inc | $10,510,000 | -15.8% | 36,208 | -20.6% | 4.04% | -17.1% |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $10,136,000 | +25.5% | 81,641 | +12.7% | 3.89% | +23.6% |
| EXEL | Buy | Exelixis Inc | $9,566,000 | +11.3% | 444,534 | +14.5% | 3.67% | +9.5% |
| ADMS | Adamas Pharmaceuticals Inc | $9,550,000 | +8.1% | 370,000 | 0.0% | 3.67% | +6.4% | |
| BMRN | Buy | Biomarin Pharmaceutical Inc | $9,164,000 | +73.2% | 97,284 | +49.0% | 3.52% | +70.5% |
| INCY | Buy | Incyte Corp | $8,442,000 | +38.8% | 125,975 | +72.6% | 3.24% | +36.7% |
| STML | Stemline Therapeutics Inc | $7,862,000 | +4.6% | 492,930 | 0.0% | 3.02% | +3.0% | |
| LGND | Sell | Ligand Pharmaceuticals Inc | $7,250,000 | +4.5% | 35,000 | -16.7% | 2.78% | +2.9% |
| HALO | Buy | Halozyme Therapeutics Inc | $7,227,000 | +2.9% | 428,633 | +19.5% | 2.78% | +1.2% |
| SAGE | Sell | Sage Therapeutics Inc | $6,726,000 | -40.7% | 42,996 | -39.0% | 2.58% | -41.6% |
| GILD | Sell | Gilead Sciences Inc | $6,397,000 | -35.4% | 90,284 | -31.2% | 2.46% | -36.4% |
| SPPI | New | Spectrum Pharmaceuticals Inc | $6,285,000 | – | 300,000 | +100.0% | 2.41% | – |
| ABMD | New | Abiomed Inc | $5,400,000 | – | 13,200 | +100.0% | 2.07% | – |
| IONS | Ionis Pharmaceuticals Inc | $5,271,000 | -5.5% | 126,500 | 0.0% | 2.02% | -6.9% | |
| SHPG | Sell | Shire plcsponsored adr | $4,220,000 | -71.5% | 25,000 | -74.7% | 1.62% | -71.9% |
| XENT | Buy | Intersect Ent Inc | $4,189,000 | +188.5% | 112,000 | +202.7% | 1.61% | +184.3% |
| TRXC | Transenterix Inc | $3,823,000 | +154.4% | 889,082 | 0.0% | 1.47% | +150.5% | |
| ALNY | Alnylam Pharmaceuticals Inc | $3,624,000 | -17.3% | 36,800 | 0.0% | 1.39% | -18.6% | |
| SRPT | Sarepta Therapeutics Inc | $3,568,000 | +78.4% | 27,000 | 0.0% | 1.37% | +75.6% | |
| VSTM | Buy | Verastem Inc | $3,435,000 | +188.2% | 500,000 | +25.0% | 1.32% | +183.7% |
| BLUE | Bluebird Bio Inc | $3,137,000 | -8.1% | 20,000 | 0.0% | 1.20% | -9.5% | |
| GTHX | Sell | G1 Therapeutics Inc | $3,121,000 | -18.1% | 72,000 | -30.1% | 1.20% | -19.4% |
| AGIO | Agios Pharmaceuticals Inc | $3,074,000 | +3.0% | 36,500 | 0.0% | 1.18% | +1.4% | |
| DCPH | Deciphera Pharmaceuticals Inc | $3,028,000 | +96.4% | 77,000 | 0.0% | 1.16% | +93.2% | |
| SGEN | Seattle Genetics Inc | $2,821,000 | +26.9% | 42,500 | 0.0% | 1.08% | +24.9% | |
| JAZZ | Sell | Jazz Pharmaceuticals PLC | $2,791,000 | -2.7% | 16,200 | -14.7% | 1.07% | -4.1% |
| MDGL | New | Madrigal Pharmaceuticals Inc | $2,790,000 | – | 10,000 | +100.0% | 1.07% | – |
| PBYI | Buy | Puma Biotechnology Inc | $2,732,000 | +18.2% | 46,300 | +36.2% | 1.05% | +16.3% |
| KALV | Kalvista Pharmaceuticals Inc | $2,612,000 | -13.2% | 322,436 | 0.0% | 1.00% | -14.5% | |
| FGEN | FibroGen Inc | $1,963,000 | +35.5% | 31,400 | 0.0% | 0.75% | +33.5% | |
| CBAY | Cymabay Therapeutics Inc | $1,945,000 | +3.2% | 145,000 | 0.0% | 0.75% | +1.6% | |
| MRUS | Merus N V | $1,692,000 | +21.6% | 75,060 | 0.0% | 0.65% | +19.7% | |
| SGMO | Buy | Sangamo Therapeutics Inc | $1,605,000 | +59.9% | 113,000 | +113.2% | 0.62% | +57.1% |
| GMED | Globus Med Inc | $1,463,000 | +1.2% | 29,000 | 0.0% | 0.56% | -0.4% | |
| GWPH | GW Pharmaceuticals Plcads | $1,339,000 | +23.8% | 9,600 | 0.0% | 0.51% | +21.8% | |
| SUPN | Supernus Pharmaceuticals Inc | $1,253,000 | +30.7% | 20,953 | 0.0% | 0.48% | +28.6% | |
| HZNP | Horizon Pharma Plc | $1,142,000 | +16.6% | 69,000 | 0.0% | 0.44% | +14.9% | |
| PRTK | Paratek Pharmaceuticals Inc | $1,051,000 | -21.9% | 103,500 | 0.0% | 0.40% | -23.0% | |
| RIGL | Rigel Pharmaceuticals Inc | $1,043,000 | -19.9% | 370,000 | 0.0% | 0.40% | -21.3% | |
| AERI | Aerie Pharmaceuticals Inc | $998,000 | +24.4% | 14,779 | 0.0% | 0.38% | +22.4% | |
| ONCE | Spark Therapeutics Inc | $992,000 | +24.2% | 12,000 | 0.0% | 0.38% | +22.1% | |
| FOLD | Amicus Therapeutics Inc | $915,000 | +3.9% | 58,600 | 0.0% | 0.35% | +2.0% | |
| PTLA | Portola Pharmaceuticals Inc | $906,000 | +15.6% | 24,000 | 0.0% | 0.35% | +13.7% | |
| CRVS | New | Corvus Pharmaceuticals Inc | $892,000 | – | 81,341 | +100.0% | 0.34% | – |
| SBPH | Spring Bk Pharmaceuticals Inc | $860,000 | -21.2% | 73,000 | 0.0% | 0.33% | -22.5% | |
| VKTX | Viking Therapeutics Inc | $664,000 | +117.7% | 70,000 | 0.0% | 0.26% | +114.3% | |
| RDUS | Radius Health Inc | $554,000 | -17.9% | 18,799 | 0.0% | 0.21% | -19.0% | |
| RSLS | Sell | ReShape Lifesciences Inc | $121,000 | -89.4% | 52,546 | -93.3% | 0.05% | -89.7% |
| FOMX | Exit | Foamix Pharmaceuticals Ltd | $0 | – | -63,202 | -100.0% | -0.13% | – |
| ESPR | Exit | Esperion Therapeutics Inc | $0 | – | -10,000 | -100.0% | -0.28% | – |
| ANAB | Exit | Anaptysbio Inc | $0 | – | -8,500 | -100.0% | -0.34% | – |
| ACAD | Exit | Acadia Pharmaceuticals Inc | $0 | – | -42,773 | -100.0% | -0.38% | – |
| TSRO | Exit | Tesaro Inc | $0 | – | -21,300 | -100.0% | -0.48% | – |
| OPTN | Exit | Optinose Inc | $0 | – | -65,000 | -100.0% | -0.51% | – |
| BGNE | Exit | BeiGene Ltdsponsored adr | $0 | – | -9,500 | -100.0% | -0.62% | – |
| PEN | Exit | Penumbra Inc | $0 | – | -14,000 | -100.0% | -0.63% | – |
| AXGN | Exit | Axogen Inc | $0 | – | -50,000 | -100.0% | -0.71% | – |
| MTEM | Exit | Molecular Templates Inc | $0 | – | -247,587 | -100.0% | -0.77% | – |
| RARE | Exit | Ultragenyx Pharmaceutical Inc | $0 | – | -41,000 | -100.0% | -0.82% | – |
| AVXS | Exit | Avexis Inc | $0 | – | -17,000 | -100.0% | -0.82% | – |
| SGYPQ | Exit | Synergy Pharmaceuticals DEL | $0 | – | -1,505,809 | -100.0% | -1.06% | – |
| CLVS | Exit | Clovis Oncology Inc | $0 | – | -76,000 | -100.0% | -1.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.